Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;31(9):2939-48.

Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis

Sharif B Mohr  1 , Edward D Gorham, John E Alcaraz, Christopher J Kane, Caroline A Macera, J Kellogg Parsons, Deborah L Wingard, Cedric F Garland
Affiliations
  • PMID: 21868542

Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis

Sharif B Mohr et al. Anticancer Res. 2011 Sep.

Erratum in

  • Anticancer Res. 2011 Oct;31(10):3637

Abstract

Background: Low serum levels of 25-hydroxyvitamin D [25(OH)D] have been associated with a high risk of breast cancer. Since publication of the most current meta-analysis of 25(OH)D and breast cancer risk, two new nested case-control studies have emerged.

Materials and methods: A PubMed search for all case-control studies on risk of breast cancer by 25(OH)D concentration identified 11 eligible studies. Data from all 11 studies were combined in order to calculate the pooled odds ratio of the highest vs. lowest quantile of 25(OH)D across all studies.

Results: The overall Peto odds ratio summarizing the estimated risk in the highest compared to the lowest quantile across all 11 studies was 0.61 (95% confidence interval 0.47, 0.80).

Conclusion: This study supports the hypothesis that higher serum 25(OH)D levels reduce the risk of breast cancer. According to the review of observational studies, a serum 25(OH)D level of 47 ng/ml was associated with a 50% lower risk of breast cancer.

PubMed Disclaimer

Publication types

LinkOut - more resources